The α -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptors are glutamategated cation channels that mediate fast excitatory synaptic transmission in the central nervous system (CNS). AMPARs are tetramers formed by homo-or heteromeric assembly of GluA1 to GluA4 subunits to produce multiple subtypes with varying biophysical properties. Polyamine toxins such as joro spider toxins, philanthotoxins and argiotoxins are use-dependent ion channel blockers of AMPARs widely employed as highly potent antagonists of GluA2-lacking receptor subtypes. In addition to this use, recent findings have indicated that a philanthotoxin analogue PhTX-74 can distinguish among GluA2-containing AMPAR subtypes in the presence of the prototypical transmembrane AMPAR regulatory protein γ-2 (or stargazin). Thus, PhTX-74 may be of potential use in studies of the neurobiological role of GluA2-containing subtypes. We have evaluated the pharmacological profile of PhTX-74 and related polyamine toxins at homo-and heteromeric AMPARs in the presence and absence of γ-2. Determination of IC 50 values for inhibition of glutamate-evoked currents from Xenopus oocytes expressing recombinant homo-or heteromeric combinations of GluA1, GluA2 and GluA3 in the presence of γ-2 show that PhTX-74 inhibits homomeric GluA1 and GluA3 receptors non-selectively with IC 50 values in the nanomolar range (252 to 356 nM), and heteromeric GluA1/A2 and GluA2/A3 receptors non-selectively with IC 50
INTRODUCTION
AMPA receptors (AMPARs) are glutamate-gated cation-selective channels that mediate fast excitatory neurotransmission in all regions of the CNS (Traynelis et al., 2010) . AMPARs are formed by homo-or heterotetrameric assembly of GluA1, GluA2, GluA3 and GluA4 subunits (Traynelis et al., 2010) . In each subunit, three of the four membrane-embedded segments (M1 to M3) contribute to forming the central ion channel which is related in structure to potassium channels (Wollmuth and Sobolevsky, 2004 ). An X-ray crystallographic structure of a homomeric GluA2 AMPAR from rat is available, but providing only limited resolution of the pore region (Sobolevsky et al., 2009 ). The amino acid sequence of the M1-M3 segments is identical across GluA1-4 and channel properties are highly similar among homomeric AMPAR subtypes. However, in the mature CNS, posttranscriptional editing of GluA2 mRNA changes a codon encoding a neutral glutamine (Q) to a positively charged arginine (R) at the position in M2 that forms the selectivity filter at the core of the ion channel pore (denoted the Q/R site; Fig. 1A ) (Burnashev et al., 1992; Verdoorn et al., 1991) .
Four glutamines thus constitute the selectivity filter in GluA2-lacking AMPARs, whereas subtypes containing edited GluA2 (GluA2 R ) comprises a mixture of arginine and glutamine residues ( Fig.   1A ). GluA2 R -containing AMPARs exhibit markedly different channel properties compared to GluA2 R -lacking AMPARs such as lower single-channel conductance (Swanson et al., 1997) , greatly reduced Ca 2+ -permeability (Geiger et al., 1995; Lomeli et al., 1994) , and a linear current-voltage (IV) relationship (Sommer et al., 1991; Verdoorn et al., 1991) . In addition to GluA2 R content, several classes of AMPAR-interacting transmembrane proteins regulate channel function, acting as auxiliary subunits. These include the transmembrane AMPAR regulatory proteins (TARPs), the cornichons homologs (CNIH) and the cysteine-knot AMPAR modulating protein (CKAMP44) (Diaz, 2010; Jackson and Nicoll, 2011a) . Association with TARPs varies in different CNS regions M O L # 8 9 9 6 1 6 and contribute diversification of key properties among native AMPARs (Coombs et al., 2012; Jackson et al., 2011; Jackson and Nicoll, 2011b; Shelley et al., 2012; Tomita et al., 2005) .
The AMPAR ion channel contains a binding site for low-molecular weight polyaminecontaining natural products that act as channel blockers. These include natural occurring arthropod toxins such as philanthotoxins (PhTXs), joro spider toxins, and argiotoxins. Binding of polyamine toxins is dependent on channel activation and membrane potential and are therefore classified as use-and voltage-dependent blockers. Structure-activity relationship and molecular modeling studies (Andersen et al., 2006; Barygin et al., 2011; Nelson et al., 2009; Tikhonov, 2007) have suggested a binding mode in which the polyamine toxin head group moiety is positioned in the channel vestibule with the polyamine tail permeating the Q/R-site ( Fig. 1A) . The presence of arginine at the Q/R-site in GluA2 R -containing AMPARs is the only molecular determinant found to influence polyamine toxin binding among different AMPAR subtypes. Specifically, the positively charged arginine side chain contributed by GluA2 R dramatically lowers toxin affinity for the ion channel binding site (Herlitze et al., 1993) . Consequently, polyamine toxins typically display more than 100fold selectivity for AMPARs lacking GluA2 R compared to those containing GluA2 R (Brackley et al., 1993; Kromann et al., 2002; Sager et al., 2009b; Washburn and Dingledine, 1996) and have become important pharmacological tools to distinguish among AMPAR subtypes in native receptor populations. In particular, as sensitivity to polyamine channel block often correlate with high Ca 2+permeability, externally applied polyamine toxin is often used to achieve selective inhibition of Ca 2+ -permeable AMPAR subtypes; although certain populations of AMPARs has been reported to exhibit Ca 2+ permeability without any appreciable block by polyamines (Meucci et al., 1996; Osswald et al., 2007; Otis et al., 1995) .
The PhTX analogue PhTX-74 has recently been reported to distinguish between two subtypes of GluA2 R -containing AMPARs, GluA1/A2 R and GluA2 R /A3 receptors, when these are M O L # 8 9 9 6 1 7 expressed in the presence of the prototypical TARP stargazin (γ-2) (Nilsen and England, 2007) .
GluA1/A2 R and GluA2 R /A3 receptors are abundantly expressed subtypes in the mature CNS and are important for synaptic plasticity (Malenka, 2003; Malinow and Malenka, 2002) , but cannot be distinguished pharmacologically because of lack of selective ligands. The potential use of polyamine toxins such as PhTX-74 as subtype-selective antagonists of heteromeric AMPARs is therefore of great interest. In the present study, we have evaluated prototypical polyamine toxins as subtype-selective AMPAR antagonists at homo-and heteromeric AMPARs. In particular, we examine the effect of γ-2 on the inhibitory potency (IC 50 ) of PhTX-74 at heteromeric GluA1/A2 R and GluA2 R /A3. We find that PhTX-74 is not selective among GluA1/A2 R and GluA2 R /A3 receptors regardless of the presence or absence of γ-2.
M O L # 8 9 9 6 1 8 , -343 were synthesized as previously described (Kromann et al., 2002) . All other chemicals were from Sigma-Aldrich (St Louis, MO) unless otherwise noted. Kainic acid was from Abcam (Cambridge, UK). ,where Response is the agonist-evoked current response measured at a given inhibitor concentration normalized to the agonist-evoked current response in absence of inhibitor, IC 50 is the concentration of inhibitor that produces a half-maximal inhibition, X is the logarithm of the concentration of the inhibitor concentration, and n H is the Hill slope. Unless otherwise indicated, statistical differences were analyzed using ANOVA followed by a Dunnett's Multiple Comparison Test using GraphPad Prism software.
MATERIALS AND METHODS

Materials
Expression of AMPARs in
M O L # 8 9 9 6 1 1 1 we determined the ratio of steady-state currents evoked by GLU and the weak partial agonist kainic acid (KA) as a test for functional expression and co-assembly of γ-2 with the AMPAR in oocytes (Kott et al., 2009; Kott et al., 2007; Sager et al., 2009a; Tomita et al., 2005) . AMPAR association with γ-2 increases the receptor current response to KA relatively more than GLU; resulting from changed AMPAR kinetics by the co-assembly with γ-2. Therefore, determination of the KA to GLU (KA/GLU) current response ratio provides a convenient and robust test for functional expression of AMPARs in complex with γ-2 (Kott et al., 2009; Kott et al., 2007; Sager et al., 2009a; Shi et al., 2009; Tomita et al., 2005) . In corroboration with previous findings (Kott et al., 2009; Kott et al., 2007; Sager et al., 2009a; Shi et al., 2009; Tomita et al., 2005; Turetsky et al., 2005) , we found that co-expression of γ-2 increased the KA/GLU ratio more than 20-fold from approximately 1 to 25 for both homomeric GluA1 and GluA3 ( Fig. 2A and B ). For heteromeric GluA1/A2 R and GluA2 R /A3 in absence of γ-2 co-expression, we also observed KA/GLU response ratios close to 1 (1.2 + 0.1 and 0.6 + 0.1, respectively), which increased to 6 and 7, respectively, upon co-expression of γ-2 (Fig. ). These results are in good agreement with previous findings Shi et al., 2009; Tomita et al., 2005; Turetsky et al., 2005) . For all batches of AMPAR expressing oocytes injected with γ-2, we determined the KA/GLU response ratio to ensure functional co-expression of γ-2. In general, we observed that less than 2% of oocytes expressing homomeric (GluA1 and GluA3) or heteromeric (GluA1/A2 R and GluA2 R /A3) AMPARs co-injected with γ-2 displayed smaller than 5-fold increases in KA/GLU ratio compared to controls not injected with γ-2 (data not shown); demonstrating a very consistent expression of AMPARs in functional complex with γ-2
RESULTS
Expression of homomeric and heteromeric
across oocyte batches. It should be noted that little biochemical evidence for the stoichiometry of TARP assembly with recombinant or native heteromeric AMPARs currently is available. Therefore, a potential caveat for the use of an increased KA/GLU response ratio as evidence for γ-2 complex formation with heteromeric receptors is that the observed shift in KA/GLU ratio could reflect effects on a contaminating subpopulation of homomeric receptors. We also expressed homomeric GluA2 R in the presence and absence of γ-2. As previously observed (Eugene et al., 1996; Koike et al., 2000) , homomeric GluA2 R in the absence of γ-2 did not express to the oocyte cell membrane at levels that allowed detection of agonist-evoked currents by TEVC electrophysiology (data not shown). However, in the presence of γ-2, we measured robust GLU-evoked current responses from all oocyte batches injected with GluA2 R (946 + 299 nA, n = 13). In agreement with previous studies , we find that the KA/GLU ratio for homomeric GluA2 R co-expressed with γ -2 was close to 1 (1. Verdoorn et al., 1991) . Representative IV relationships are shown in Fig. 2C and 2D for homo-and heteromeric AMPARs in the absence and presence of γ-2, respectively. From these, we calculated rectification ratios (RR) as the ratio of current amplitude at +40 mV, which reflects primarily GluA2 R -containing heteromeric receptor current, to that at −60 mV. For homomeric GluA1 and GluA3 expressed in the absence of γ-2, RR was 0.04 and 0.08, respectively ( Fig. 2E ). Co-expression of γ-2 significantly increased RR for GluA1 to 0.15 ( Fig. 2E ). The decrease in rectification by co-expression of γ-2 that was observed for homomeric GluA1 has previously been reported, and is suggested to result from a slightly decreased sensitivity towards channel block by intracellular polyamines induced by association with γ-2 (Soto et al., 2007) .
Interestingly, this effect was not present for homomeric GluA3 as RR did not significantly change upon co-expression with γ-2. Expression of heteromeric receptors in the presence or absence of γ-2
showed RR levels close to the theoretically expected value of 0.67 that reflect a linear IV relationship in the −60 to +40 mV range, which is expected for channels insensitive to intracellular polyamine block (Fig 2C-E) . This shows that the cRNA co-injection regimen used to co-express GluA1 or GluA3 with GluA2 R generates an AMPAR population that is predominantly composed of heteromeric receptors; both in the absence and the presence of γ-2.
Determination of PhTX-74 inhibitory potency at GluA1/A2 R and GluA2 R /A3 in the presence and absence of γ-2 -PhTX-74 in the micromolar concentration range has been reported to display selective inhibition between the two major subtypes of GluA2 R -containing AMPARs, GluA1/A2 R and GluA2 R /A3, when these are co-expressed with γ-2 in oocytes (Nilsen and England, 2007) .
Specifically, PhTX-74 was reported to fully inhibit GluA1/A2 R receptors when applied at a concentration of 500 µM while producing ~10% inhibition at GluA2 R /A3 receptors (Nilsen and England, 2007) , thus suggesting that PhTX-74 could distinguish between these subtypes in native AMPAR populations. To further investigate these aspects, we examined PhTX-74 and other This article has not been copyedited and formatted. The final version may differ from this version. polyamine PhTX analogues at homo-and heteromeric AMPARs expressed in the presence and absence of γ-2. First, to determine the influence of AMPAR subunit type on PhTX analogue affinity with glutamine at the Q/R-site, we expressed GluA1, GluA2 Q , GluA3 and GluA4 as homomeric receptors in oocytes in the absence of γ-2. We compared inhibition of GLU-evoked currents by a series of close PhTX analogues with subtle modifications in the polyamine moiety, previously determined to possess variable AMPAR affinity (Kromann et al., 2002) (Supplemental Fig.S1 ).
When tested at a single concentration of 1 µM at holding potentials of -60 and -80 mV, all compounds displayed percent inhibition that were identical or differed by less than 20% inhibition at the four homomeric AMPARs (Supplemental Fig. S1 ). The largest differences were observed for PhTX-47, PhTX-83 and PhTX-74 (Supplemental Fig. S1 ). Among these we selected PhTX-47 for determination of concentration-inhibition relationships to determine the precise differences in inhibitory potency between homomeric GluA1 to GluA4 (Supplemental Fig. S1 ). The resulting IC 50 values were within 2-fold range of each other (Supplemental Fig. S1 ). These results suggest that the structural and functional differences that exists among the four AMPAR subunits has marginal influence on the affinities of PhTX analogues for the AMPAR ion channel when glutamines is present in the Q/R site.
We next focused on the influence of γ-2 on affinities of PhTX analogues at homo-and heteromeric AMPARs composed of the GluA1, GluA3 and GluA2 R subunits. Specifically, we expressed GluA1, GluA2 R and GluA3 as homomeric receptors and as heteromeric GluA1/A2 R and GluA2 R /A3 receptors in the presence and absence of γ-2 and determined the concentrationinhibition relationship for PhTX-74 over a concentration range from 10 nM to 300 µM (Fig. 3) . At homomeric GluA1 and GluA3, the resulting concentration-inhibition curves produced IC 50 values that were not significantly different from each other (296 nM and 263 nM, respectively; P = 0.20;
Student's t test) ( Table 1) . As mentioned previously, we could not express homomeric GluA2 R in This article has not been copyedited and formatted. The final version may differ from this version. oocytes at levels that allowed measurement of agonist evoked currents (and could therefore not determine the IC 50 value of PhTX-74 at this subtype). Co-expression of γ-2 with homomeric GluA1 and GluA3 did not change the IC 50 values for PhTX-74 inhibition significantly (P = 0.62 for GluA1 with and without γ-2; P=0.12 for GluA3 with and without γ-2; Student's t test) ( Fig. 3 and Table 1 ).
The results for homomeric GluA1 and GluA3 receptors are in agreement with previous findings for homomeric GluA4 receptors that showed co-expression of TARPs, including γ-2, to have minimal effect on PhTX-74 inhibition when GLU is used as agonist (Jackson et al., 2011) . For heteromeric GluA1/A2 R and GluA2 R /A3 in the absence of γ-2, the concentration-inhibition data showed that PhTX-74 displayed little or no measureable inhibition at toxin concentrations below 1 µM (Fig. 3 ).
In the micromolar concentrations range, significant inhibition where observed for both heteromeric subtypes; reaching 80 % and 81% inhibition at the maximum tested concentration (300 µM). The concentration-inhibition relationships progressed near identical and were fitted well to a monophasic concentration-inhibition curve defined by a one-binding site model with IC 50 values of 52 (GluA1/A2 R ) and 49 (GluA2 R /A3) µM that were not significantly different (p = 0.59; Student's t test) (Fig. 3A) . Co-expression with γ-2 decreased IC 50 approximately 2-fold at both GluA1/A2 R and GluA2 R /A3 (both 22 µM; P < 0.0001 compared to IC 50 without γ-2) ( Fig. 3B and Table 1 ). These results show that PhTX-74 is non-selective among the tested heteromeric AMPAR subtypes both in the presence and in the absence of γ-2. In addition, the presence of γ-2 has little effect on GluA1/A2 R and GluA2 R /A3 for PhTX-74 inhibitory potency during activation by GLU.
The robust GLU-evoked currents (946 + 299 nA, n = 13) that were obtained from oocytes injected with GluA2 R and γ-2 cRNA allowed characterization of PhTX-74 at homomeric GluA2 R receptors. In agreement with previous findings (Nilsen and England, 2007) , we found that homomeric GluA2 R receptors were virtually insensitive to PhTX-74 when applied in concentrations up to 300 µM (Fig. 3B ). Comparison of this result with the data obtained at homomeric GluA1 and M O L # 8 9 9 6 1 1 6 heteromeric receptors GluA1/A2 R expressed with γ-2 reveal the substantial negative impact on polyamine block that is produced by incremental increase in the number of arginines in the Q/R-site from zero (homomeric GluA1 and GluA3) to two (GluA1/A2 R and GluA2 R /A3) and four (homomeric GluA2 R ).
This article has not been copyedited and formatted. The final version may differ from this version. GluA2 R and either GluA1 or GluA3 can also express homomeric GluA1, homomeric GluA3 and homomeric GluA2 R . In the present study, we used measurements of the rectification ratios to ensure that individual oocytes co-injected with GluA2 R and GluA1 or GluA3 express a receptor population devoid of homomeric GluA1 or GluA3. Because of their characteristic inward rectified IVrelationship, the extent of homomeric GluA1 and GluA3 content can be assessed electrophysiologically by measuring this ratio (Kristensen et al., 2011) and used to exclude oocytes expressing detectable amounts of homomeric GluA1 or GluA3 receptors. Furthermore, even when present, homomeric GluA1 and GluA3 are >95% inhibited by PhTX-74 concentration of 10 µM (Fig. 3) , and therefore for all practical means do not contribute to the progress of concentrationinhibition relationship in the 10 to 300 µM concentration range. In terms of the potential presence of homomeric GluA2 R , we find that these receptors do not express in oocytes in the absence of γ-2 and can therefore be ruled out as a concern for the concentration-inhibition relationships determined in the absence of γ-2. However, in the presence of γ-2, we do find that homomeric GluA2 R are readily expressed to the membrane in oocytes to generate ~1000 nA currents. Furthermore, these currents have an IV-relationship very similar to GluA1/A2 R or GluA2 R /A3 (Fig. 2C and D) .
Therefore, if a substantial proportion of homomeric GluA2 R are present in experiments with coexpression of γ-2, these will contribute current that cannot be distinguished from heteromeric receptors. In particular, in conditions seeking GluA2 R /A3 receptors, carefully balanced expression ratios of GluA2 R and GluA3 is important for avoiding formation of homomeric GluA2 given the suggestion that GluA3 is trafficked poorly compared to the other AMPAR subunits (Coleman et al., 2010) . In the present study, we observe from experiments with oocytes expressing GluA2 R alone that homomeric GluA2 R is virtually inert to PhTX-74 in the 0.1 to 300 µM concentration range;
displaying < 5% inhibition at the maximum tested concentration of 300 µM (Fig. 3B ). Together, these findings ensure that the obtained PhTX-74 concentration-inhibition relationships at the 10 to This article has not been copyedited and formatted. The final version may differ from this version. 300 µM PhTX-74 concentration range at oocytes co-injected with GluA2 R and GluA1 or GluA3 accurately reflect the inhibitory activity of PhTX-74 at heteromeric GluA1/A2 R and GluA2 R /A3
receptors. Thus, we conclude that PhTX-74 inhibit these receptors non-selectively with IC 50 values around 30 µM; both in the presence and absence of γ-2. By establishing that PhTX-74 is nonselective among these important heteromeric AMPAR subtypes, our findings may have implications for conclusions drawn in previous work utilizing PhTX-74 to study native AMPARs (Argilli et al., 2008; Penn et al., 2012) . It should be noted that our work characterizes the potency of PhTX-74 at homomeric and heteromeric AMPAR subtypes under equilibrium conditions (i.e. during continued activation by saturating concentrations of GLU). In relation to the potential use of PhTX-74 in studies of synaptic transmission, it is important to note that synaptic AMPARs are activated by brief millisecond pulses of GLU. The kinetics of external polyamine toxin block under these conditions are essentially unknown and consequently, the amount of block achieved by a given polyamine toxin concentration at synapses may therefore be different than those reported in the present study.
Previous work has shown that TARPs modulate polyamine channel block differentially among AMPAR subtypes (Jackson et al., 2011; Kott et al., 2009; Soto et al., 2007) . In general, our present observations that γ -2 increases the potency of externally applied PhTX-74 at heteromeric AMPARs, but not at homomeric AMPARs is in good agreement with previous findings (Jackson et al., 2011; Kott et al., 2009) . AMPARs activate the ion channel into multiple subconductance states (Swanson et al., 1997) . It has been proposed that the high-affinity polyamine toxin binding site may be less accessible in the channel configurations underlying low-conductance states compared to high-conductance states (Bahring and Mayer, 1998; Jackson et al., 2011) . Apparent polyamine toxin affinity may thus increase under conditions that increase the ability of the ion channel to open to high-conductance states . Specifically, this has been demonstrated for PhTX-74
at homomeric GluA4 and heteromeric GluA2 R /A4 receptors using differential TARP co-expression M O L # 8 9 9 6 1 2 0 and activation by low-efficacy versus high-efficacy agonists to modulate mean channel conductance; hereby establishing a strong correlation between mean channel conductance and apparent PhTX-74 affinity (Jackson et al., 2011) . Heteromeric GluA2-containing receptors display very low mean conductance during activation with GLU (Jackson et al., 2011; Kristensen et al., 2011; Swanson et al., 1997) . Co-expression with γ -2 and other TARPs increases the mean conductance of heteromeric AMPARs during GLU activation approximately two-to threefold (Jackson et al., 2011; Kristensen et al., 2011) . Thus, as previously observed for GluA2 R /A4 (Jackson et al., 2011) , our observed increases in PhTX-74 potency upon co-expression by γ -2 for GluA1/A2 R and GluA2 R /A3 might therefore reflect an increase in availability of high conductance states. In contrast to the effect on external channel block, γ -2 decreases the extent of internal channel block by endogenous polyamines such as spermine and spermidine (Soto et al., 2007) . The molecular basis for these contrasting effects of γ -2 is currently poorly understood, but likely reflects the differences in the chemical structure of intracellular polyamines and polyamine toxins such as PhTX. Specifically, endogenous intracellular polyamines do not contain a bulky head group and can permeate the AMPAR ion channel at high positive membrane potentials (Bowie and Mayer, 1995) .
TARP-mediated increase in the occurrence of high-conductance states has therefore been suggested to facilitate permeation intracellular polyamines, which will be manifest in a decrease in channel block at high positive potentials (Jackson et al., 2011; Soto et al., 2007) .
Our present data suggest that polyamine toxins, at least of the PhTX class, are poor candidates as tools to distinguish among GluA2-containing AMPAR subtypes. At present, two other AMPAR binding sites for inhibitors are known in the form of the orthosteric binding site in the ligand-binding domain that is targeted by competitive antagonists and a binding site for negative allosteric modulators located within the linker region that connect the LBDs to the ion channel domain (Traynelis et al., 2010) . Similar to the polyamine toxin blockers, subtype-selective M O L # 8 9 9 6 1 2 1
competitive antagonists have proven difficult to obtain. This is also likely due to a high degree of structural conservation among GluA1 to GluA4 in the orthosteric binding pocket. The binding pocket for negative allosteric modulators has been mapped to the S1-M1 and S2-M4 linker subunit regions that connect the LBD to the ion channel domain (Balannik et al., 2005) . These segments contain a higher degree of sequence variation among GluA1-4 compared to the near identical M1-M4 regions and orthosteric binding pockets (Sobolevsky et al., 2009 ). Thus, non-competitive modulators exemplified by the 2,3-benzodiazepine class of GYKI compounds (Szenasi et al., 2008) and the more potent piraquilone derivatives (Menniti et al., 2000) Table 1 .
This article has not been copyedited and formatted. The final version may differ from this version. 
